- Pioneer in High Throughput SNP Discovery Brings Expertise in Human Genome Haplotyping -
PHILADELPHIA, Oct. 14 /PRNewswire/ -- BioNanomatrix, Inc., a developer of breakthrough nanoscale platforms for genetic diagnostics, personalized medicine and biomedical research, today announced the appointment of noted medical genomics researcher Pui-Yan Kwok, M.D., Ph.D., to its Scientific Advisory Board (SAB). Dr. Kwok is Henry Bachrach Distinguished Professor at the University of California, San Francisco.
Dr. Kwok's research is focused on the development of new approaches to whole genome analysis and their application to gene mapping and haplotyping. He pioneered the high throughput discovery of single nucleotide polymorphisms (SNPs) across the human genome and was a member of the International HapMap Consortium Steering Committee. The inventor of several fluorescence-based SNP genotyping methods, Dr. Kwok more recently has been developing mapping and haplotyping methods based on microscopic analysis of single DNA molecules. He has authored over 110 publications and holds three patents.
"Pui-Yan has extensive experience in single-molecule DNA mapping and haplotyping, both as a distinguished research leader and as an inventor of novel genotyping methods," said Dr. Han Cao, chief scientific officer of BioNanomatrix. "His expertise should be especially valuable as we further develop our platform to image and analyze individual DNA molecules for the high-resolution mapping of labeled genomic sites, a project which is supported by a recent NIH grant to BioNanomatrix."
BioNanomatrix is applying its expertise in nanochips, nanodevices and
nanosystems to develop its patented platform technology to provide fast,
comprehensive, and low-cost analysis of genomic, epigenomic and proteomic
information with sensitivity at the single-molecule level. Its current
development efforts include a federally funded project in partnership with
|SOURCE BioNanomatrix, Inc.|
Copyright©2008 PR Newswire.
All rights reserved